2018 annual financial data
Celldex Therapeutics 2018 Operating cash flow margin
Direct answer
Operating cash flow margin was -788.79%.
Operating income was -156,436,000 USD and net income was -151,184,000 USD.
Operating cash flow was -75,235,000 USD.
Get free Celldex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 9,538,000 USD
- Operating income
- -156,436,000 USD
- Net income
- -151,184,000 USD
- Operating cash flow
- -75,235,000 USD